iANTHUS CAPITAL HOLDINGS (ITHUF) Share-based Compensation (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Share-based Compensation came in at $504000.0 in Q1 2026, down 3.26% year-on-year from $521000.0 in Q1 2025, and up 54.13% quarter-over-quarter from $327000.0 in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Share-based Compensation (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Share-based Compensation across 7 years of filings, most recently posting $504000.0 for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $504000.0, down 3.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 14.6% YoY), and the FY2025 annual result was $1.8 million, down 12.43% from the prior year.
- Share-based Compensation came in at $504000.0 for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $327000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $21.0 million in Q2 2022 to a low of $200000.0 in Q3 2022.
- The 5-year median for Share-based Compensation is $521000.0 (2025), against an average of $2.0 million.
- Across the five-year window, Share-based Compensation jumped 1164.3% in 2022 and plunged 92.38% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Share-based Compensation stood at $2.9 million in 2022, then sank by 66.64% to $980000.0 in 2023, then plunged by 56.84% to $423000.0 in 2024, then fell by 22.7% to $327000.0 in 2025, then soared by 54.13% to $504000.0 in 2026.
- The last three Share-based Compensation figures came in at $504000.0 (Q1 2026), $327000.0 (Q4 2025), and $400000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 504,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 504,000.00 |
| Mar 31, 2026 | 504,000.00 |
| Dec 31, 2025 | 327,000.00 |
| Dec 31, 2025 | 327,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Dec 31, 2024 | 423,000.00 |
| Dec 31, 2024 | 423,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 434,000.00 |
| Mar 31, 2024 | 434,000.00 |
| Dec 31, 2023 | 980,000.00 |
| Dec 31, 2023 | 980,000.00 |